RhythmAnalytics vs SENSICARDIAC

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RhythmAnalytics

by Biofourmis Singapore Pte.

SENSICARDIAC

by Diacoustic Medical Devices (Pty) Ltd.

AI Verdict

RhythmAnalytics is designed for automated interpretation of cardiac arrhythmias from ECG data, providing clinical decision support for rhythm disorders. SENSICARDIAC, conversely, focuses on AI-powered detection and classification of heart murmurs using electronic stethoscope input. The selection of either tool would depend on whether the primary diagnostic need is for arrhythmia analysis or heart murmur screening.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is comprehensive, automated interpretation of a wide range of cardiac arrhythmias from single-lead ECG data. This tool is ideal for clinical decision support in settings where precise detection of various rhythm disorders, including AFib and ventricular arrhythmias, from devices like Holter monitors or wearable sensors is crucial for patient management.

View RhythmAnalytics →

Choose SENSICARDIAC if…

Choose SENSICARDIAC if your focus is on efficient and accurate AI-powered heart murmur detection, particularly when integrating with electronic stethoscopes. This solution is best suited for physicians aiming to quickly classify murmurs as pathological or physiological, thereby reducing unnecessary referrals and enhancing initial diagnostic workflows, especially in telehealth or pediatric settings.

View SENSICARDIAC →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RhythmAnalytics	SENSICARDIAC
Pricing	Contact vendor	Unknown
Deployment	Cloud-based API	SensiCardiac is a software package running on a Windows PC that interfaces with compatible electronic stethoscopes. SensiCardiac Mobi runs on a mobile device (iPhone 4S or later) and interfaces with a hosted Linux server environment. The related Telesensi platform operates entirely in the browser.
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SENSICARDIAC

SENSICARDIAC offers a more direct and guided user experience for clinicians, featuring a graphical interface for auscultation, real-time analysis, and downloadable reports. RhythmAnalytics, conversely, is primarily a cloud-based API designed for integration into other systems, meaning its direct usability is for developers rather than end-user clinicians.

Clinical Value

RhythmAnalytics

Both tools are FDA-cleared and provide significant clinical value in cardiology. However, RhythmAnalytics demonstrates a broader scope within its domain by detecting over 15 types of cardiac arrhythmias with high sensitivity (90.8%) and specificity (98.2%), and has shown to outperform human cardiologists and other AI systems in its specific function. SENSICARDIAC focuses on classifying heart murmurs as pathological or physiological, which is also valuable but less broadly defined in its diagnostic output.

Pricing & Value

Tie

Neither RhythmAnalytics nor SENSICARDIAC provides publicly available pricing information, both requiring direct contact with the vendor. Without transparent pricing or detailed value propositions, it is not possible to conduct a meaningful comparison of their cost-effectiveness or overall value.

Enterprise Readiness

SENSICARDIAC

SENSICARDIAC explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical for enterprise adoption [JSON]. Its associated platform, Telesensi, also provides features like user management, billing, and white-labeling options for integrators. While RhythmAnalytics is a cloud-based API suitable for integration, its BAA status is unspecified in the provided facts, which is a key differentiator for enterprise-level data handling [JSON].

Innovation

SENSICARDIAC

While both leverage AI for cardiac diagnostics, SENSICARDIAC's integration of AI with live diagnostic quality stethoscope streaming and a guided auscultation process represents a direct and tangible innovation in a traditional clinical examination [JSON, cite: 22, 23]. This approach enhances the physical exam for remote care and potentially broadens access to accurate heart murmur screening. RhythmAnalytics' advanced deep learning for ECG interpretation is also innovative, but SENSICARDIAC's application to the auscultation workflow is particularly novel.

Support & Docs

SENSICARDIAC

SENSICARDIAC, through its related Telesensi platform, explicitly mentions offering 'timely, reliable and agile support' and provides engineers for integration assistance, with user manuals also available. In contrast, the provided information for RhythmAnalytics does not detail specific support structures or public documentation, making SENSICARDIAC appear more transparent in its support offerings.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RhythmAnalytics	SENSICARDIAC
Name	RhythmAnalytics	SENSICARDIAC
Company	Biofourmis Singapore Pte.	DIACOUSTIC MEDICAL (PTY)
Primary Function	AI-powered automated interpretation of cardiac arrhythmias from single-lead ECG data.	AI-powered heart murmur detection and classification (pathological/physiological).
Input Data Type	Single-lead ECG data	Electronic stethoscope data
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology, Internal Medicine, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and SENSICARDIAC.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing clinical workflow and address different cardiac care needs?

RhythmAnalytics integrates as a cloud-based API into existing cardiac monitoring solutions or directly into medical devices and wearable sensors, providing automated interpretation of cardiac arrhythmias from single-lead ECG data for clinical decision support. SENSICARDIAC, conversely, integrates with electronic stethoscopes to guide physicians through auscultation, offering real-time AI-powered heart murmur detection and classification with downloadable detailed cardiac reports.

What is the reported accuracy and sensitivity of each tool in detecting their respective cardiac conditions?

RhythmAnalytics has demonstrated a sensitivity of 90.8% and specificity of 98.2% in detecting over 15 types of cardiac arrhythmias, with studies indicating it can outperform a panel of cardiologists. SENSICARDIAC reports an accuracy of over 95% for its AI-powered heart murmur detection service, classifying murmurs as either pathological or physiological.

For which specific patient populations or clinical scenarios is each tool best suited?

RhythmAnalytics is well-suited for cardiology, emergency medicine, and internal medicine, particularly for continuous monitoring and interpretation of various cardiac arrhythmias in adult patients using data from FDA-cleared ECG devices. SENSICARDIAC is primarily designed for cardiology, internal medicine, and pediatrics, assisting in the diagnosis of heart murmurs and helping to reduce unnecessary referrals for echocardiograms.

What is the typical learning curve for physicians, and what kind of support is available for each tool?

While RhythmAnalytics' API-based integration suggests a need for technical integration, its clinical decision support aims to simplify ECG interpretation, and Biofourmis' partnerships with leading hospitals imply professional support. SENSICARDIAC features a guided auscultation process and an intuitive user interface to potentially lower the learning curve, with training provided during onboarding and a commitment to timely, reliable, and agile support.

What is the expected time-to-value for a practice implementing these tools, and what considerations are there for multi-site rollouts?

For RhythmAnalytics, time-to-value depends on existing infrastructure due to its API integration, but Biofourmis' experience with large health systems and zero-touch provisioning workflows suggests scalability for multi-site deployments. SENSICARDIAC's cloud-based user management and billing system simplifies multi-site rollouts, allowing centralization of multiple facilities, and its browser-based design facilitates easier deployment and faster integration into existing telehealth workflows.